Beak and feather disease virus candidate vaccine development

Includes bibliographical references. === [Fix supervisors field.] Psittacine beak and feather disease, caused by a circovirus known as beak and feather disease virus (BFDV), is a threat to both wild and captive psittacine species. There is currently no vaccine against BFDV and safe and affordable va...

Full description

Bibliographic Details
Main Author: Duvenage, Lucian
Other Authors: Rybicki, Ed
Format: Dissertation
Language:English
Published: University of Cape Town 2015
Subjects:
Online Access:http://hdl.handle.net/11427/12785
id ndltd-netd.ac.za-oai-union.ndltd.org-uct-oai-localhost-11427-12785
record_format oai_dc
spelling ndltd-netd.ac.za-oai-union.ndltd.org-uct-oai-localhost-11427-127852020-10-06T05:11:32Z Beak and feather disease virus candidate vaccine development Duvenage, Lucian Rybicki, Ed Hitzeroth, Inga Meyers, Ann Molecular and Cell Biology Includes bibliographical references. [Fix supervisors field.] Psittacine beak and feather disease, caused by a circovirus known as beak and feather disease virus (BFDV), is a threat to both wild and captive psittacine species. There is currently no vaccine against BFDV and safe and affordable vaccine candidates are needed to alleviate the disease burden caused by this virus. Production of the BFDV's major antigenic determinant, the capsid protein (CP), in the inexpensive and highly scalable plant expression system, could satisfy these requirements as a potential subunit vaccine. In this work, truncated CP (ÄN40 CP) was first expressed in E. coli to successfully generate anti-CP polyclonal antibodies. ÄN40 CP and full-length CP transient expression in tobacco (Nicotiana benthamiana) was optimised as fusions to elastin-like polypeptide (ELP). Fusion of CP or ÄN40 CP to ELPs of different lengths was shown to increase yield relative to unfused CP/ÄN40 CP. Free ELP and a GFP-ELP fusion could be purified by inverse transition cycling (ITC), using centrifugation and membrane filtration methods. A ÄN40 CP-ELP fusion expressed in plants could be partially purified and represents low-cost vaccine candidate against BFDV. A candidate DNA vaccine expressing ÄN40 CP was also evaluated for expression of the antigen in vitro and may prove useful in a prime-boost regimen together with one of the plant-produced vaccine candidates. 2015-05-13T14:15:55Z 2015-05-13T14:15:55Z 2012 Master Thesis Masters MSc http://hdl.handle.net/11427/12785 eng application/pdf University of Cape Town Faculty of Science Department of Molecular and Cell Biology
collection NDLTD
language English
format Dissertation
sources NDLTD
topic Molecular and Cell Biology
spellingShingle Molecular and Cell Biology
Duvenage, Lucian
Beak and feather disease virus candidate vaccine development
description Includes bibliographical references. === [Fix supervisors field.] Psittacine beak and feather disease, caused by a circovirus known as beak and feather disease virus (BFDV), is a threat to both wild and captive psittacine species. There is currently no vaccine against BFDV and safe and affordable vaccine candidates are needed to alleviate the disease burden caused by this virus. Production of the BFDV's major antigenic determinant, the capsid protein (CP), in the inexpensive and highly scalable plant expression system, could satisfy these requirements as a potential subunit vaccine. In this work, truncated CP (ÄN40 CP) was first expressed in E. coli to successfully generate anti-CP polyclonal antibodies. ÄN40 CP and full-length CP transient expression in tobacco (Nicotiana benthamiana) was optimised as fusions to elastin-like polypeptide (ELP). Fusion of CP or ÄN40 CP to ELPs of different lengths was shown to increase yield relative to unfused CP/ÄN40 CP. Free ELP and a GFP-ELP fusion could be purified by inverse transition cycling (ITC), using centrifugation and membrane filtration methods. A ÄN40 CP-ELP fusion expressed in plants could be partially purified and represents low-cost vaccine candidate against BFDV. A candidate DNA vaccine expressing ÄN40 CP was also evaluated for expression of the antigen in vitro and may prove useful in a prime-boost regimen together with one of the plant-produced vaccine candidates.
author2 Rybicki, Ed
author_facet Rybicki, Ed
Duvenage, Lucian
author Duvenage, Lucian
author_sort Duvenage, Lucian
title Beak and feather disease virus candidate vaccine development
title_short Beak and feather disease virus candidate vaccine development
title_full Beak and feather disease virus candidate vaccine development
title_fullStr Beak and feather disease virus candidate vaccine development
title_full_unstemmed Beak and feather disease virus candidate vaccine development
title_sort beak and feather disease virus candidate vaccine development
publisher University of Cape Town
publishDate 2015
url http://hdl.handle.net/11427/12785
work_keys_str_mv AT duvenagelucian beakandfeatherdiseaseviruscandidatevaccinedevelopment
_version_ 1719349591849041920